REPLi: Identify Protease Substrates

Do you have an unidentified protease? Do you want to know its target sequence?

A Rapid Endopeptidase Profiling Library (REPLi) is a generic Fluorescent Resonance Energy Transfer (FRET) Peptide Library designed specifically to overcome common hurdles and simplify the protease profiling process. Mimotopes’ REPLi Library is available off-the-shelf and ready to use from our online catalogue.

Find out more

REPLi Requirements

An advantage of REPLi is it doesn’t require any prior knowledge of the proteases under investigation to help define the sequence of the protease cleavage site.

This peptide library comprises 3375 peptides divided into 512 distinct pools, each containing only 8 peptides so it can be rapidly deconvoluted to identify the specific sequences cleaved by your proteases.

Proteases are valuable drug targets in disease treatment, therefore fast identification of protease substrates directly from cells and tissues is invaluable.

How FRET Functions

FRET is commonly used to investigate protein interactions, including proteolysis.

In REPLi, the tripeptide core sequence is book-ended by glycine residues, with a fluorescent donor and quenching acceptor on opposite ends. When proteases cleave the peptide sequence, the quenching effect ends and the donor fluoresces.

Through real time proteolytic activity monitoring, this peptide library design provides a quantitative measure of the differences in substrate processing of low-abundant proteins, as disease markers.

Is REPLi Reliable?

Validation studies with well-characterised representative proteases from each of the four mechanistic protease classes have shown the impressively specific and sensitive capabilities of REPLi.

Results obtained from REPLi can be followed up with precise directed analysis using purified custom peptides or peptide libraries.

CONTACT US TODAY

for a peptide quote! 

☎ +61 3 9565 1111

✉ australia@mimotopes.com

☎ +1 651 603 0909

 useast@mimotopes.com

☎ +61 3 9565 1111

✉ asia@mimotopes.com

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Contact us today

for a peptide quote! 

Australia

☎ +61 3 9565 1111

✉ australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

 useast@mimotopes.com

✉ uswest@mimotopes.com

asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com


UK / Europe / Africa / Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Contact us today

 for a peptide quote! 

Australia

☎ +61 3 9565 1111

australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

  ✉ useast@mimotopes.com 
  ✉ uswest@mimotopes.com

asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com

UK/ Europe/ Africa/ Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Go to article: Home | Clinics ration supplies as cancer drug shortages proliferateGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Owen Mumford Company InsightGo to article: Owen MumfordGo to article: In DepthGo to article: Clinics ration supplies as cancer drug shortages proliferateGo to article: Asian countries prioritise rare disease market access amid stark disparities Go to article: Supercritical fluids advance sterilisation tech in pharmaGo to article: Fighting AMR with a value and subscription modelGo to article: Q&A: How can the US maintain access to essential drugs?Go to article: Inflation reduction act boosts biologic VC financing over small moleculesGo to article: NiproGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: ForewordGo to article: An introduction to artificial intelligenceGo to article: A history of artificial intelligenceGo to article: The impact of artificial intelligence on the pharmaceutical sectorGo to article: Case studies: artificial intelligence in the pharmaceutical industryGo to article: Latest news: artificial intelligence in pharmaGo to article: Q&A with GlobalData thematic analystGo to article: Rx Machina: how AI is transforming pharma sales Go to article: Artificial intelligence innovation: leading companies in in-silico drug discovery Go to article: Leading clinical trials companies in the artificial intelligence theme Go to article: Deal activity related to artificial intelligence in the pharmaceutical industry since 2020Go to article: Artificial intelligence hiring trends in the global pharmaceutical industry since 2020Go to article: Artificial intelligence patent applications in the global pharmaceutical industry since 2020Go to article: Mentions of artificial intelligence in pharmaceutical industry company filings since 2020Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: ListingsGo to article: EventsGo to article: Event: 10th Annual Outsourcing In Clinical Trials UK And Ireland 2023Go to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue